Published Nov 13, 2026, 10:48 AM ET · Updated 6 hours ago · 1 source
Blackstone is becoming a biotech bank
axios
·
Original Report
INFERY
Blackstone Life Sciences has agreed to pay Pfizer up to $1.5 billion to finance development of a monthly GLP-1 receptor agonist.